APA (7th ed.) Citation

Rimini, M., Fornaro, L., Lonardi, S., Niger, M., Lavacchi, D., Pressiani, T., . . . Caliman, E. (2023). Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data. Liver International, 43(8), 1803. https://doi.org/10.1111/liv.15641

Chicago Style (17th ed.) Citation

Rimini, Margherita, et al. "Durvalumab Plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer: An Early Exploratory Analysis of Real‐world Data." Liver International 43, no. 8 (2023): 1803. https://doi.org/10.1111/liv.15641.

MLA (9th ed.) Citation

Rimini, Margherita, et al. "Durvalumab Plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer: An Early Exploratory Analysis of Real‐world Data." Liver International, vol. 43, no. 8, 2023, p. 1803, https://doi.org/10.1111/liv.15641.